Cloughesy, T. F., Alexander, B. M., Berry, D. A., Colman, H., De Groot, J. F., Ellingson, B. M., … Yung, W. K. A. (2022). GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Cloughesy, Timothy Francis, Brian Michael Alexander, Donald A. Berry, Howard Colman, John Frederick De Groot, Benjamin M. Ellingson, Gary B. Gordon, et al. “GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Cloughesy TF, Alexander BM, Berry DA, Colman H, De Groot JF, Ellingson BM, et al. GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Cloughesy, Timothy Francis, et al. “GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Cloughesy TF, Alexander BM, Berry DA, Colman H, De Groot JF, Ellingson BM, Gordon GB, Khasraw M, Lassman AB, Lee EQ, Lim M, Mellinghoff IK, Nelli A, Perry JR, Sulman EP, Tanner K, Weller M, Wen PY, Yung WKA. GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. 2022.